KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Johnson & Johnson (JNJ) Non Operating Income (2016 - 2025)

Johnson & Johnson (JNJ) has disclosed Non Operating Income for 17 consecutive years, with -$483.0 million as the latest value for Q4 2025.

  • Quarterly Non Operating Income fell 400.0% to -$483.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.2 billion through Dec 2025, up 253.58% year-over-year, with the annual reading at $7.2 billion for FY2025, 253.58% up from the prior year.
  • Non Operating Income hit -$483.0 million in Q4 2025 for Johnson & Johnson, down from $478.0 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $7.3 billion in Q1 2025 to a low of -$6.9 billion in Q2 2023.
  • Historically, Non Operating Income has averaged -$384.0 million across 5 years, with a median of -$249.5 million in 2022.
  • Biggest YoY gain for Non Operating Income was 2133.33% in 2021; the steepest drop was 14612.5% in 2021.
  • Year by year, Non Operating Income stood at -$1.8 billion in 2021, then surged by 87.78% to -$226.0 million in 2022, then skyrocketed by 286.28% to $421.0 million in 2023, then plummeted by 61.76% to $161.0 million in 2024, then tumbled by 400.0% to -$483.0 million in 2025.
  • Business Quant data shows Non Operating Income for JNJ at -$483.0 million in Q4 2025, $478.0 million in Q3 2025, and -$107.0 million in Q2 2025.